T1	Condition 0 12	Tuberculosis
T2	Qualifier 13 25	resistant to
T3	Drug 37 48	study drugs
T4	Drug 50 59	isoniazid
T5	Drug 61 69	rifampin
T6	Drug 71 74	EMB
T7	Drug 76 79	PZA
T8	Drug 81 84	CFZ
T9	Drug 86 89	Pto
*	OR T9 T8 T7 T6 T5 T4
T10	Scope 50 89	isoniazid, rifampin, EMB, PZA, CFZ, Pto
R1	Subsumes Arg1:T3 Arg2:T10	
R2	AND Arg1:T2 Arg2:T3	
R3	Has_qualifier Arg1:T1 Arg2:T2	
T11	Observation 92 123	Unable to take oral medications
T12	Condition 137 144	allergy
T13	Observation 126 133	History
T14	Condition 148 159	intolerance
*	OR T12 T14
T15	Drug 174 185	study drugs
T16	Scope 137 159	allergy or intolerance
R4	Has_temporal Arg1:T16 Arg2:T13	
R5	AND Arg1:T16 Arg2:T15	
T17	Measurement 187 209	Serum aminotransferase
T18	Measurement 211 214	AST
T19	Measurement 218 221	ALT
*	OR T18 T19
T20	Scope 211 221	AST or ALT
R6	Subsumes Arg1:T17 Arg2:T20	
T21	Scope 187 222	Serum aminotransferase (AST or ALT)
T22	Value 223 257	3x upper limit of normal or higher
R7	Has_value Arg1:T21 Arg2:T22	
T23	Condition 259 267	Pregnant
T24	Observation 271 278	nursing
T25	Person 279 286	females
*	OR T23 T24 T30
T26	Mood 291 298	plan to
T27	Observation 299 314	become pregnant
T28	Observation 318 323	nurse
T29	Temporal 324 347	during the study period
*	OR T27 T28
T30	Scope 299 323	become pregnant or nurse
R8	Has_mood Arg1:T30 Arg2:T26	
R9	Has_temporal Arg1:T30 Arg2:T29	
T31	Person 349 354	Males
T32	Mood 355 366	planning to
T33	Observation 367 383	conceive a child
R10	Has_mood Arg1:T33 Arg2:T32	
T34	Temporal 384 400	during the study
T35	Temporal 404 445	within 6 months of cessation of treatment
T36	Reference_point 423 445	cessation of treatment
R11	Has_index Arg1:T35 Arg2:T36	
T37	Reference_point 391 400	the study
R12	Has_index Arg1:T34 Arg2:T37	
*	OR T34 T35
T38	Scope 384 445	during the study or within 6 months of cessation of treatment
R13	Has_scope Arg1:T33 Arg2:T38	
T39	Qualifier 479 485	active
T40	Condition 486 498	tuberculosis
T41	Temporal 499 550	within 6 months preceding initiation of study drugs
R14	Has_qualifier Arg1:T40 Arg2:T39	
R15	Has_temporal Arg1:T40 Arg2:T41	
T42	Procedure 452 461	treatment
R16	AND Arg1:T42 Arg2:T40	
T43	Condition 577 589	tuberculosis
T44	Qualifier 604 626	central nervous system
T45	Qualifier 634 639	bones
T46	Qualifier 647 653	joints
T47	Qualifier 662 682	miliary tuberculosis
T48	Qualifier 690 714	pericardial tuberculosis
*	OR T44 T45 T46 T47 T48
T49	Scope 604 714	central nervous system and/or bones and/or joints, and/or miliary tuberculosis and/or pericardial tuberculosis
R17	Has_scope Arg1:T43 Arg2:T49	
T50	Mood 566 576	documented
T51	Mood 553 562	Suspected
*	OR T51 T50
T52	Scope 553 576	Suspected or documented
R18	Has_scope Arg1:T43 Arg2:T52	
T53	Condition 717 729	HIV infected
T54	Condition 731 743	HBV infected
T55	Condition 747 759	HCV infected
*	OR T54 T55
T56	Non-representable 760 819	(these increase the risk of TB-drug induced hepatotoxicity)
T57	Measurement 821 827	Weight
T58	Value 828 845	less than 40.0 kg
R19	Has_value Arg1:T57 Arg2:T58	
T59	Condition 854 861	allergy
T60	Condition 865 876	intolerance
T61	Drug 891 908	study medications
*	OR T59 T60
T62	Scope 854 876	allergy or intolerance
R20	AND Arg1:T62 Arg2:T61	
T63	Condition 993 1016	M. tuberculosis isolate
T64	Qualifier 1040 1075	resistant to any of the study drugs
T65	Drug 1064 1075	study drugs
R21	multi Arg1:T64 Arg2:T65	
R22	Has_qualifier Arg1:T63 Arg2:T64	
T66	Measurement 1078 1082	QTcF
T67	Value 1083 1093	> 500 msec
R23	Has_value Arg1:T66 Arg2:T67	
T68	Non-query-able 1095 1222	Other medical conditions, that, in the investigator's judgment, make study participation not in the individual's best interest.
T69	Temporal 1224 1231	Current
T70	Mood 1235 1242	planned
*	OR T69 T70
T71	Observation 1243 1256	incarceration
T72	Observation 1266 1287	involuntary detention
*	OR T71 T72
T73	Scope 1243 1287	incarceration or other involuntary detention
T74	Scope 1224 1242	Current or planned
R24	Has_scope Arg1:T73 Arg2:T74	
T75	Observation 1296 1334	participated in other clinical studies
T76	Drug 1350 1372	investigational agents
T77	Temporal 1373 1408	within 8 weeks prior to trial start
T78	Temporal 1412 1421	currently
T79	Observation 1422 1458	enrolled in an investigational study
T80	Reference_point 1397 1408	trial start
R25	Has_index Arg1:T77 Arg2:T80	
R26	Has_temporal Arg1:T79 Arg2:T78	
R27	Has_temporal Arg1:T75 Arg2:T77	
R28	AND Arg1:T75 Arg2:T76	
T81	Drug 1488 1504	medicinal agents
R29	AND Arg1:T79 Arg2:T81	
T82	Non-representable 1506 1665	Subjects who are participating in observational studies or who are in a follow up period of a trial that included drug therapy may be considered for inclusion.
